Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
McGill University Health Centre/Research Institute of the McGill University Health Centre
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults with end-stage renal disease (stage 5 CKD), who were on a stable in-center hemodialysis regimen (approximately 4 hours 3 times per week) for ≥ 12 weeks prior to recruitment
A cardiac evaluation was required within the last year to ensure adequate cardiac function
You may not be if
Any physical or psychological disability that would impact study participation, such as severe cerebrovascular disease (e.g., hemiparesis, cerebellar ataxia, etc.) or dementia
Serum intact parathyroid hormone(iPTH)\>250 pmol/L within 30 days prior to screening visit
Dysrhythmia or severe cardiac disease, such as congestive heart failure (CHF) Class III-IV, or unstable cardiovascular disease within 90 days prior to recruitment
Severe peripheral arterial disease
Severe hyperkalemia (\>6.5 milliequivalent/L) consistently the last 2 weeks
Current active cancer (excluding basal cell carcinoma of the skin)
Poorly controlled hypertension (post-dialytic systolic blood pressure ≥ 160mmHg or diastolic blood pressure≥ 100 mmHg) within 4 weeks prior to recruitment
Anticipated living donor kidney transplant or any other planned major surgery over the study duration
